Vaxcyte Inc.

PCVX | NASDAQ

Price Alert Chart Builder DCF Calculator

$58.92

+$0.79 (+1.36%)

At close: Sep 21, 2026, 4:00 PM ET

$58.11

-$0.81 (-1.37%)

Pre-market: Sep 22, 2026, 4:01 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	1.41M
Gross Profit	n/a	n/a	n/a	n/a	n/a	-1.41M
Operating Income	-923.68M	-569.55M	-468.04M	-232.26M	-103.67M	-89.58M
Interest Income	119.72M	109.99M	62.91M	8.36M	344K	244K
Pretax Income	-766.63M	-463.93M	-402.27M	-223.49M	-100.08M	-89.22M
Net Income	-766.63M	-463.93M	-402.27M	-223.49M	-100.08M	-89.22M
Selling & General & Admin	129.37M	92.9M	60.7M	39.81M	25.26M	14.61M
Research & Development	794.31M	476.64M	332.34M	169.45M	78.41M	73.56M
Other Expenses	n/a	n/a	75M	23M	n/a	n/a
Operating Expenses	923.68M	569.55M	468.04M	232.26M	103.67M	88.18M
Interest Expense	n/a	n/a	n/a	2K	7K	7K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	923.68M	569.55M	468.04M	232.26M	103.67M	89.58M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	136.09M	122M	97.16M	64.88M	51.92M	29.55M
Shares Outstanding (Diluted)	136.09M	122M	97.16M	64.88M	51.92M	29.55M
EPS (Basic)	-5.63	-3.80	-4.14	-3.44	-1.93	-2.97
EPS (Diluted)	-5.63	-3.80	-4.14	-3.44	-1.93	-2.97
EBITDA	-741.77M	-448.08M	-392.1M	-214.03M	-96.61M	-87.81M
EBIT	-766.63M	-463.93M	-402.27M	-223.48M	-100.07M	-89.21M
Depreciation & Amortization	24.86M	15.85M	10.17M	9.45M	3.46M	1.41M